Randall W. Moreadith

Randall W. Moreadith is the current President & CEO at Serina Therapeutics. Prior to this, they were the Chief Development Officer at Nektar Therapeutics from July 2008 to December 2009. Moreadith has also held the position of Executive VP and Chief Medical Officer at Cardium Therapeutics from January 2006 to August 2008, as well as Chief Medical Officer at Renovis, Inc. from January 2004 to January 2005. Randall co-Founded ThromboGenics, Ltd. with a scientific colleague Professor Desire Collen in December 1996, where they served as President and Chief Operating Officer until December 2003.

Randall W. Moreadith's educational career began with him being a Howard Hughes Fellow at Harvard University in the field of Molecular Genetics. Randall then went on to get their MD in Internal Medicine - Cardiology from Duke University School of Medicine. Finally, they got their Doctor of Philosophy - PhD in Cell/Cellular and Molecular Biology from The Johns Hopkins University School of Medicine.